A61K 51/0425
Compounds containing methylenedioxyphenol groups
Official title: {compounds containing methylenedioxyphenol groups, e.g. sesamin}
A61K51/0425 (Compounds containing methylenedioxyphenol groups) appears on 4 US grants and 5 published applications in this corpus.
Search patents in A61K- Granted patents
- 4
- Published applications
- 5
- Assignees
- 4
- Inventors
- 7
- Latest grant
- 17 Nov 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 1 | 0 |
By publication year.
Recent patents
- Aryloxyanilide imaging agents17 Nov 2015US 9,186,424 B2Ge Healthcare Limited
- Aryloxyanilide imaging agents8 Jul 2014US 8,771,641 B2Ge Healthcare Limited
- Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy14 Dec 2010US 7,850,948 B2Bayer Schering Pharma Aktiengesellschaft
- Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy23 Sep 2008US 7,427,390 B2Schering Corporation
- Aryloxyanilide imaging agents25 Sep 2014US 2014/0288317 A1Ge Healthcare Limited
- Aryloxyanilide imaging agents27 Sep 2012US 2012/0244073 A1Ge Healthcare Limited
- Inhibitors of integrin vla-416 Jul 2009US 2009/0180951 A1Molecular Insight Pharmaceuticals, Inc.
- Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy8 Jan 2009US 2009/0012090 A1Bayer Schering Pharma Aktiengesellschaft
- Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy22 Sep 2005US 2005/0207972 A1Schering Corporation
Most cited
By later US patents